Found: 81
Select item for more details and to access through your institution.
Effect of replacing cefotaxime with ceftizoxime in a hospital where penicillin-resistant pneumococcal disease is prevalent.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 3, p. 1, doi. 10.1093/ofid/ofv085
- By:
- Publication type:
- Article
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 1, p. 1, doi. 10.1093/ofid/ofu113
- By:
- Publication type:
- Article
The case against anergy testing as a routine adjunct to tuberculin skin testing.
- Published in:
- 2000
- By:
- Publication type:
- journal article
The Effects of Perceived Stress and Cortisol Concentration on Antiretroviral Adherence When Mediated by Psychological Flexibility Among Southern Black Men Living with HIV.
- Published in:
- AIDS & Behavior, 2021, v. 25, n. 2, p. 645, doi. 10.1007/s10461-020-03016-8
- By:
- Publication type:
- Article
Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapy.
- Published in:
- Journal of NeuroVirology, 2004, v. 10, p. 33, doi. 10.1080/13550280490268214
- By:
- Publication type:
- Article
Pharmacogenetics of Long-Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 11, p. 1931, doi. 10.1086/497610
- By:
- Publication type:
- Article
Pharmacogenomics and HIV Therapeutics.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Immunophenotypic Markers and Antiretroviral Therapy (IMART): T Cell Activation and Maturation Help Predict Treatment Response.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 10, p. 1811, doi. 10.1086/383277
- By:
- Publication type:
- Article
Treatment with Indinavir, Efavirenz, and Adefovir after Failure of Nelfinavir Therapy.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 7, p. 1157, doi. 10.1086/368287
- By:
- Publication type:
- Article
Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse-Transcriptase Inhibitor Experience: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 3, p. 392
- By:
- Publication type:
- Article
Proinflammatory Cytokine and Human Immunodeficiency Virus RNA Levels during Early Mycobacterium avium Complex Bacteremia in Advanced AIDS.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 6, p. 1746, doi. 10.1086/517437
- By:
- Publication type:
- Article
Impaired Hepatic Protein Synthesis in AIDS Patients with Low Vitamin A Levels.
- Published in:
- Journal of Infectious Diseases, 1995, v. 172, n. 4, p. 1167
- By:
- Publication type:
- Article
Extremely low-coverage sequencing and imputation increases power for genome-wide association studies.
- Published in:
- Nature Genetics, 2012, v. 44, n. 6, p. 631, doi. 10.1038/ng.2283
- By:
- Publication type:
- Article
Genetic and Non-Genetic Determinants of Raltegravir Penetration into Cerebrospinal Fluid: A Single Arm Pharmacokinetic Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082672
- By:
- Publication type:
- Article
T Cell Activation Markers and African Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials Group Study 384.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043803
- By:
- Publication type:
- Article
HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins.
- Published in:
- PLoS ONE, 2009, v. 4, n. 8, p. 1, doi. 10.1371/journal.pone.0006687
- By:
- Publication type:
- Article
Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinical and Genetic Determinants of Plasma Nevirapine Exposure Following an Intrapartum Dose to Prevent Mother-to-Child HIV Transmission.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 4, p. 662, doi. 10.1093/infdis/jit223
- By:
- Publication type:
- Article
Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 5, p. 749, doi. 10.1093/infdis/jis753
- By:
- Publication type:
- Article
Impact of UGT1A1 Gilbert Variant on Discontinuation of Ritonavir-Boosted Atazanavir in AIDS Clinical Trials Group Study A5202.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 3, p. 420, doi. 10.1093/infdis/jis690
- By:
- Publication type:
- Article
Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, n. 5, p. 717, doi. 10.1086/655470
- By:
- Publication type:
- Article
African Mitochondrial DNA Subhaplogroups and Peripheral Neuropathy during Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 11, p. 1703, doi. 10.1086/652419
- By:
- Publication type:
- Article
CYP2B6 Variants and Plasma Efavirenz Concentrations during Antiretroviral Therapy in Port-au-Prince, Haiti.
- Published in:
- Journal of Infectious Diseases, 2009, v. 200, n. 6, p. 955, doi. 10.1086/605126
- By:
- Publication type:
- Article
Associations between CYP2B6 Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 6, p. 872, doi. 10.1086/597125
- By:
- Publication type:
- Article
Hemochromatosis Gene Polymorphisms, Mitochondrial Haplogroups, and Peripheral Lipoatrophy during Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 6, p. 858, doi. 10.1086/528697
- By:
- Publication type:
- Article
Human Genomic Association Studies: A Primer for the Infectious Diseases Specialist.
- Published in:
- Journal of Infectious Diseases, 2007, v. 195, n. 12, p. 1737, doi. 10.1086/518247
- By:
- Publication type:
- Article
Toward a Pharmacogenetic Understanding of Nucleotide and Nucleoside Analogue Toxicity.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Immunogenetics of CD4 Lymphocyte Count Recovery during Antiretroviral Therapy: An AIDS Clinical Trials Group Study.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 8, p. 1098, doi. 10.1086/507313
- By:
- Publication type:
- Article
Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 1, p. 78, doi. 10.1067/mcp.2003.11
- By:
- Publication type:
- Article
Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 4, p. 367, doi. 10.1067/mcp.2000.109391
- By:
- Publication type:
- Article
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults.
- Published in:
- PLoS Genetics, 2021, v. 17, n. 4, p. 1, doi. 10.1371/journal.pgen.1009464
- By:
- Publication type:
- Article
Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 5, p. 1247, doi. 10.1111/bcp.16009
- By:
- Publication type:
- Article
Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 1, p. 146, doi. 10.1111/bcp.12590
- By:
- Publication type:
- Article
Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 4, p. 997, doi. 10.1111/j.1365-2125.2012.04454.x
- By:
- Publication type:
- Article
Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2018, v. 32, n. 5, p. 431, doi. 10.1002/rcm.8058
- By:
- Publication type:
- Article
The Transition of Adolescent Males To First Sexual Intercourse: Anticipated or Delayed?
- Published in:
- Perspectives on Sexual & Reproductive Health, 2002, v. 34, n. 4, p. 184, doi. 10.2307/3097728
- By:
- Publication type:
- Article
Identification of a CCR5-Expressing T Cell Subset That Is Resistant to R5-Tropic HIV Infection.
- Published in:
- PLoS Pathogens, 2007, v. 3, n. 4, p. e58, doi. 10.1371/journal.ppat.0030058
- By:
- Publication type:
- Article
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 973, doi. 10.1093/cid/ciab598
- By:
- Publication type:
- Article
Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor–Containing Regimens.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e2153, doi. 10.1093/cid/ciaa1219
- By:
- Publication type:
- Article
Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 10, p. 1820, doi. 10.1093/cid/ciaa975
- By:
- Publication type:
- Article
Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 6, p. 1044, doi. 10.1093/cid/ciy764
- By:
- Publication type:
- Article
Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1860, doi. 10.1093/cid/civ155
- By:
- Publication type:
- Article
Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 12, p. 1860, doi. 10.1093/cid/civ155
- By:
- Publication type:
- Article
Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 4, p. 1034, doi. 10.1002/cpt.2044
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 4, p. 726, doi. 10.1002/cpt.1477
- By:
- Publication type:
- Article
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 11, p. 1081, doi. 10.1007/s00228-009-0725-5
- By:
- Publication type:
- Article
Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 19, p. 4334, doi. 10.1093/hmg/dds226
- By:
- Publication type:
- Article
HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells.
- Published in:
- PLoS Biology, 2004, v. 2, n. 7, p. 1, doi. 10.1371/journal.pbio.0020198
- By:
- Publication type:
- Article